Profile
ARTV VRTX REGN VRNA ARGX ALNY
Company Name Artiva Biotherapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $97.93M $122.53B $81.42B $72.68B $51.58B $43.35B
Employees 0.10K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Fred Aslan Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ARTV VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
ARTV VRTX REGN VRNA ARGX ALNY
Last Close $3.51 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $12.78 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $1.47 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -72.54 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 138.78 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ARTV VRTX REGN VRNA ARGX ALNY
1 Month Return -41.6 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 13.23 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 72.91 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return -14.39 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return -65.18 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -68.94 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ARTV VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -34.38 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Growth
ARTV VRTX REGN VRNA ARGX ALNY
Asset Growth 99.38 % 7.41 % 53.91 % 10.71 %
Gross Profit Growth -99.25 % 1.16 % - 26.81 %
Revenue Growth -99.25 % 0.99 % - 22.97 %
Revenue 3 Year -90.95 % 20.64 % -15.89 % 147.1 %
Revenue 5 Year - 73.64 % - 775.72 %
Revenue 10 Year - 285.02 % - 2487.4 %
EBIT Growth -119.37 % 9.09 % -131.37 % 24.59 %
Net Income Growth -111.2 % 2.09 % -224.78 % 36.82 %
Net Income 3 Yeari Growth Per Share 41.22 % 6.32 % -148.34 % 69.73 %
Net Income 5 Yeari Growth Per Share - 31.91 % 25.82 % 73.13 %
Net Income 10 Yeari Growth Per Share - 680.22 % -35.51 % 55.09 %
Operating Income Growth -119.37 % -7.46 % -133.02 % 37.31 %
Operating Cash Flow Growth (CFG) -16.03 % - -143.33 % -107.98 %
Operating 3 Year CFG -159.52 % -100 % -170.73 % 98.8 %
Operating 5 Year CFG - -100 % 54.81 % 97.44 %
Operating 10 Year CFG - -100 % 40.15 % 97.08 %
EPS Growth -336.97 % 5.31 % -214.81 % 38.07 %
EPS Diluted Growth -336.97 % 8.19 % -208.93 % 38.07 %
Book Value Per Share 210.09 % 32.88 % -22.82 % 129.75 %
Share Holder 3 Year Equity Growth Per Share 251.59 % 41.21 % 1.82 % -89.42 %
Share Holder 5 Year Equity Growth Per Share - 191.63 % -24.45 % -96.01 %
Share Holder 10 Year Equity Growth Per Share - 842.11 % -71.86 % -95.83 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -15.13 % 0.06 % 139.05 % 110.16 %
Free Cash Flow Growth -9.84 % - -144.48 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2025 31 Dec 2024 31 Dec 2024
Profitability
ARTV VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -48.57 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -45.64 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -62.54 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 83.94 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -655.85 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM 0.78 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -3.13 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -3.22 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM 502.28 % 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.91 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -655.85 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -1.24 36.72 19.95 -995.27 129.37 195.85
Price To Operating Cash Flows Ratio TTM -1.27 32.86 16.2 -126.33 146.05 162.25
Price Cash Flow Ratio TTM -1.27 32.86 16.2 -126.33 146.05 162.25
Income Statement (TTM)
ARTV VRTX REGN VRNA ARGX ALNY
Revenue $0B $12B $14.34B $0.03B $2.19B $3.71B
Gross Profit $0B $10.35B $12.24B $0.03B $1.96B $3.04B
Gross Profit Ratio 100% 86.24% 85.35% 93.89% 89.62% 81.77%
EBITDA $-0.06B $4.69B $5.82B $-0.12B $0.11B $0.56B
Net Income $-0.06B $3.95B $4.5B $-0.14B $0.83B $0.31B
EPS Diluted -5.2 15.32 41.48 -1.73 12.78 2.33
Balance Sheet (MRQ)
ARTV VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.01B $3.69B $2.71B $0.12B $0.03B $2.7B
Total Liabilities $0.02B $6.98B $9.3B $0.27B $0.7B $4.18B
Total Equity $0.19B $18.67B $31.26B $0.2B $5.5B $0.79B
Total Investments $0.15B $5.71B $15.75B $0.02B $1.93B $1.25B
Total Debt $0.01B $3.69B $2.71B $0.12B $0.04B $2.97B
Total Assets $0.21B $25.64B $40.56B $0.47B $6.2B $4.97B
Cash Flow Statement (TTM)
ARTV VRTX REGN VRNA ARGX ALNY
Net Income $-0.07B $-0.54B $4.5B $-0.17B $0.83B $0.31B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $-0.06B $-0.49B $4.98B $-0.12B $-0.08B $0.52B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.06B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.69
AARD Aardvark Therapeutics, Inc. Common Stock 12.14
ABCL AbCellera Biologics Inc. 3.111
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.005
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.505
ABPWW 0.0131
ABSI Absci Corporation 2.545
ABUS Arbutus Biopharma Corporation 3.99
ABVC ABVC BioPharma, Inc. 1.67
ABVX Abivax SA American Depositary Shares 124.925
ACAD ACADIA Pharmaceuticals Inc. 22.04
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.84
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.205
ACIU AC Immune SA 2.98
ETFs With Exposure to ARTV
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.0001 262.95
VTI Vanguard Total Stock Market Index Fund 0.00003 336.66
IBB iShares Biotechnology ETF 0 172.59
IWN iShares Russell 2000 Value ETF 0.00011 199.845
IWO iShares Russell 2000 Growth ETF 0.00013 334.66
BIB ProShares Ultra Nasdaq Biotechnology 0.00611831 84.7
VXF Vanguard Extended Market Index Fund 0.0003 216.22
HDG ProShares Hedge Replication ETF 0.000167861 52.7
UWM ProShares Ultra Russell2000 0.000980364 53.025
VTHR Vanguard Russell 3000 Index Fund 0 301.62
IWC iShares Micro-Cap ETF 0 166.14
URTY ProShares UltraPro Russell2000 0.000784157 63.085
VTWV Vanguard Russell 2000 Value Index Fund 0.00152 176.33
VTWG Vanguard Russell 2000 Growth Index Fund 0.0017 244.475
VTWO Vanguard Russell 2000 Index Fund 0.00151 106.25
XSU.TO iShares U.S. Small Cap Index ETF (CAD-Hedged) 0 49.73
VUN.TO Vanguard U.S. Total Market Index ETF 0.00003 124.53
VUS.TO Vanguard U.S. Total Market Index ETF (CAD-hedged) 0.00003 116.8
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0.00007 113.17
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 113.15
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.12
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.11
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.11
VGRO.TO Vanguard Growth ETF Portfolio 0.00001 44.16
VEQT.TO Vanguard All-Equity ETF Portfolio 0.00001 55.46
VBAL.TO Vanguard Balanced ETF Portfolio 0.00001 37.77
VCNS.TO Vanguard Conservative ETF Portfolio 0.00001 32.11
VCIP.TO Vanguard Conservative Income ETF Portfolio 0 27.4
VRIF.TO Vanguard Retirement Income ETF Portfolio 0 27.01
IBBQ Invesco Nasdaq Biotechnology ETF 0.009618 29.45
DFAS Dimensional U.S. Small Cap ETF 0.00001934 75.64
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0 7.345
VTSAX Vanguard Total Stock Market Index Fund 0.00003 163.59
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0 8.7175
SBIO.MI Invesco NASDAQ Biotech UCITS ETF 0.0094 52.57
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.0003 162.32
VITSX Vanguard Total Stock Market Index Fund 0.00003 163.62
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0 8.684
SBIO.L Invesco NASDAQ Biotech UCITS ETF 0.0094 62.41
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.0003 162.33
BTEK.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0 6.3925
VTS.AX Vanguard US Total Market Shares Index ETF 0.00003 474.81
DCOR Dimensional ETF Trust 0.00044104 75.47
VEMPX Vanguard Extended Market Index InstlPlus 0.0003 400.57
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0.00003 306.93
RSSL Global X Funds 0 103.035
Unlock